BPA Call VA69D15A0046-VA69D15J5851
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2, is for HPV detection cost-per-test services during the option year 1 period. The contract has a ceiling value of $105,293.00 and is a firm fixed price Blanket Purchase Agreement (BPA) call order. The...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a Blanket Purchase Agreement (BPA) call placed by the U.S. Department of Veterans Affairs (VA) for HPV testing equipment, supplies, and preventative maintenance option year 3. The award ceiling value is $84,142.60 and the contract is a Firm Fixed Price arrangement under the VA's Critical Analyzers, Laboratory Master Contract (FSS-66-III) on the General Services Administration (GSA)...
- This federal contract award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 12 and Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The BPA is for the provision of HP CT/NG DNA tests on a cost-per-test basis, under the General Services Administration (GSA) Critical Analyzers, Laboratory schedule. The contract has a potential value of $146,686.34, a completion date of...
- This is a Delivery Order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation for HPV screening and genotyping services. The contract has a ceiling value of $86,355.10 and is a Firm Fixed Price type. The contract is placed against Roche's General Services Administration (GSA) Schedule 66 contract for Critical Analyzers and Laboratory Equipment. Roche has performed as a prime contractor on numerous contracts with the VA, Department of Defense, and other...
- This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA is for the provision of HP CT/NG DNA tests on a cost-per-test basis, with a potential value of $159,038.54 and a completion date of September 30, 2019. The contract is not set-aside and was awarded on...
- This is a $126,006.07 firm fixed price Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory equipment, and supplies. The contract is to provide Human Papillomavirus (HPV) testing equipment, supplies, and preventative maintenance services for a 5-year period through February 2026. This order is placed against Roche's critical analyzers laboratory equipment...
- This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation (Roche Diagnostics), a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for HP CT/NG DNA tests, priced on a cost-per-test basis, and is a renewal of an existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract. The BPA...
- This is a BPA call contract awarded by the Veterans Integrated Service Network 12 (VISN12) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract is for the provision of reagents and consumables for human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing, with a ceiling value of $175,128.60 and a performance period ending on September 30, 2021. The contract was...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 12, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for $168,053.56 and provides reagents and consumables for HPV/CT/NG testing, with a performance period ending on November 30, 2023. The contract is a Firm Fixed Price type and does...
- Roche Diagnostics Corporation has been awarded a $150.4K firm fixed-price Blanket Purchase Agreement (BPA) call for reagents and consumables to support human papillomavirus (HPV), chlamydia (CT), and neisseria gonorrhoeae (NG) testing. The contract, effective October 1, 2024, with an ultimate completion date of September 30, 2025, was awarded by Veterans Integrated Service Network 12 (a component of the Department of Veterans Affairs) with no set-aside designation. This award is a child contract...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797P7037A-VA69D15A0046Blanket Purchase Agreement
- VA69D15A0046-VA69D15J5851BPA Call
This is a federal contract award made by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation to provide HPV/CT/NG DNA testing services. The contract is a Blanket Purchase Agreement (BPA) call under Roche's existing General Services Administration (GSA) schedule contract for critical laboratory analyzers and supplies. The award has a ceiling value of $168,719.59 and was made on September 30, 2015, with a completion date of February 17, 2017. The contract does not have a set-aside designation. Roche Diagnostics is the prime contractor and has provided the VA with a variety of medical diagnostic equipment, reagents, and laboratory services through both prime and subcontract awards across multiple federal agencies including the Department of Defense and Department of Health and Human Services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($46k) | 2/17/17 | |
| Not listed | Not listed | $214.9k | 9/30/15 |